ERA is in the process of being migrated to Scholaris, a Canadian shared institutional repository service (https://scholaris.ca). Deposits to existing ERA collections are frozen until migration is complete. Please contact erahelp@ualberta.ca for further assistance
- 145 views
- 158 downloads
Synthesis of a homologous series of galactofuranose-containing mycobacterial arabinogalactan fragments
-
- Author(s) / Creator(s)
-
Mycobacteria, including the human pathogen Mycobacterium tuberculosis the causative agent of tuberculosis, produce a complex cell wall structure made of carbohydrates and lipids. The major structural element of the mycobacterial cell wall is a glycoconjugate called the mycolic acid¬–arabinogalactan–peptidoglycan (mAGP) complex. Inhibition of mAGP biosynthesis is a proven strategy for developing anti-mycobacterial drugs and thus understanding the pathways and enzymes involved in the assembly of this molecule is of interest. In this paper we describe the chemical synthesis of a panel nine oligosaccharides fragments (4–12) of the galactan domain of the mAGP complex designed as biosynthetic probes. These structures, ranging in size from a hexasaccharide to a tetradecasaccharide, are potential substrates for two biosynthetic enzymes, GlfT2 and AftA, and represent the largest mycobacterial galactan fragments synthesized to date. The route developed was iterative and provided multi-milligram quantities of the target molecules 4–12 in good overall yield.
-
- Date created
- 2019-01-31
-
- Subjects / Keywords
-
- Type of Item
- Article (Published)